The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review

A Pan, Y Wang, M Talaei, FB Hu - Circulation, 2015 - Am Heart Assoc
Background—The prevalence of smoking in diabetic patients remains high, and reliable
quantification of the excess mortality and morbidity risks associated with smoking is …

First-line therapy for type 2 diabetes with sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study

JG Choi, AN Winn, MR Skandari, MI Franco… - Annals of internal …, 2022 - acpjournals.org
Background: Guidelines recommend sodium–glucose cotransporter-2 (SGLT2) inhibitors
and glucagon-like peptide-1 (GLP1) receptor agonists as second-line therapy for patients …

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk

D Martins-Mendes, M Monteiro-Soares… - Journal of Diabetes and …, 2014 - Elsevier
Aims To estimate 3-year risk for diabetic foot ulcer (DFU), lower extremity amputation (LEA)
and death; determine predictive variables and assess derived models accuracy. Material …

[HTML][HTML] Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.

K Winkley, R Upsher, D Stahl, D Pollard… - Health technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND For people with diabetes mellitus to achieve optimal glycaemic control,
motivation to perform self-management is important. The research team wanted to determine …

[HTML][HTML] Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

ME Molitch, AI Adler, A Flyvbjerg, RG Nelson, WY So… - Kidney international, 2015 - Elsevier
The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly
throughout the world, due primarily to the increase in type 2 DM (T2DM). Although …

Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials

S Basu, JB Sussman, SA Berkowitz… - The lancet Diabetes & …, 2017 - thelancet.com
Background In view of substantial mis-estimation of risks of diabetes complications using
existing equations, we sought to develop updated Risk Equations for Complications Of type …

[HTML][HTML] DNA methylation markers for kidney function and progression of diabetic kidney disease

KY Li, CHT Tam, H Liu, S Day, CKP Lim, WY So… - Nature …, 2023 - nature.com
Epigenetic markers are potential biomarkers for diabetes and related complications. Using a
prospective cohort from the Hong Kong Diabetes Register, we perform two independent …

[HTML][HTML] Validation of the IMS CORE diabetes model

P McEwan, V Foos, JL Palmer, M Lamotte, A Lloyd… - Value in Health, 2014 - Elsevier
Abstract Background The IMS CORE Diabetes Model (CDM) is a widely published and
validated simulation model applied in both type 1 diabetes mellitus (T1DM) and type 2 …

[HTML][HTML] Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings

K Dziopa, FW Asselbergs, J Gratton, N Chaturvedi… - Diabetologia, 2022 - Springer
Aims/hypothesis We aimed to compare the performance of risk prediction scores for CVD (ie,
coronary heart disease and stroke), and a broader definition of CVD including atrial …